🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/12/1999 32,44 32,63 31,88 32,63 +1,16% 2,31% 7.117
30/12/1999 33,75 34,50 31,13 32,25 -8,51% 10,00% 20.850
29/12/1999 32,25 36,56 31,88 35,25 +9,30% 14,53% 22.717
28/12/1999 33,75 34,50 31,50 32,25 -2,27% 8,89% 25.150
27/12/1999 35,06 35,25 33,00 33,00 -6,38% 6,42% 15.150
23/12/1999 35,25 42,00 34,13 35,25 +6,21% 22,34% 104.117
22/12/1999 39,75 40,13 33,19 33,19 -14,08% 17,45% 12.800
21/12/1999 39,00 41,25 36,75 38,63 +5,10% 11,54% 29.417
20/12/1999 31,88 37,50 30,75 36,75 +12,64% 21,18% 19.417
17/12/1999 33,00 33,38 31,50 32,63 -3,33% 5,68% 5.383
16/12/1999 36,75 36,75 30,38 33,75 -2,17% 17,35% 22.883
15/12/1999 32,25 35,63 32,06 34,50 +6,98% 11,05% 11.783
14/12/1999 28,50 32,25 28,13 32,25 +7,50% 14,47% 30.967
13/12/1999 30,38 30,75 28,50 30,00 -1,23% 7,41% 43.300
10/12/1999 31,88 31,88 29,63 30,38 +0,00% 7,06% 13.533
09/12/1999 36,00 36,38 30,38 30,38 -13,83% 16,67% 8.633
08/12/1999 37,50 38,06 34,50 35,25 -6,93% 9,50% 10.300
07/12/1999 36,75 38,63 36,00 37,88 +4,12% 7,14% 7.417
06/12/1999 39,28 39,38 36,00 36,38 -5,83% 8,59% 16.917
03/12/1999 41,63 42,56 37,13 38,63 -6,36% 13,06% 12.917
02/12/1999 43,22 43,50 40,69 41,25 -3,51% 6,51% 13.150
01/12/1999 40,88 43,50 40,69 42,75 +5,56% 6,88% 33.267
30/11/1999 42,00 42,00 39,00 40,50 -0,92% 7,14% 12.817
29/11/1999 39,38 41,25 39,00 40,88 +7,92% 5,71% 10.400
26/11/1999 38,25 38,25 37,50 37,88 -0,98% 1,96% 2.800
24/11/1999 40,31 42,00 37,50 38,25 -4,67% 11,16% 12.117
23/11/1999 38,06 40,13 37,88 40,13 +2,88% 5,91% 9.850
22/11/1999 37,50 39,00 33,75 39,00 +6,12% 14,00% 9.983
19/11/1999 37,88 39,00 35,25 36,75 -3,92% 9,90% 9.667
18/11/1999 37,50 39,00 37,50 38,25 +4,08% 4,00% 4.250